These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10302873)

  • 1. Medicaid formularies: a critical review of the literature.
    Jang R
    J Pharm Mark Manage; 1988; 2(3):39-61. PubMed ID: 10302873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A critical analysis of studies of state drug reimbursement policies: research in need of discipline.
    Soumerai SB; Ross-Degnan D; Fortess EE; Abelson J
    Milbank Q; 1993; 71(2):217-52. PubMed ID: 8510601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The elimination of selected drug products from the Michigan Medicaid formulary: a case study.
    Smith DM; McKercher PL
    Hosp Formul; 1984 May; 19(5):366-72. PubMed ID: 10299510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Managing psychotropic drug costs: will formularies work?
    Huskamp HA
    Health Aff (Millwood); 2003; 22(5):84-96. PubMed ID: 14515884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cost effects of restricting cost-effective therapy.
    Bloom BS; Jacobs J
    Med Care; 1985 Jul; 23(7):872-80. PubMed ID: 3925258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The social drug lag: an examination of pharmaceutical approval delays in Medicaid formularies.
    Schweitzer SO; Salehi H; Boling N
    Soc Sci Med; 1985; 21(10):1077-82. PubMed ID: 3909437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of a transition to more restrictive drug formulary on therapy discontinuation and medication adherence.
    Shirneshan E; Kyrychenko P; Matlin OS; Avila JP; Brennan TA; Shrank WH
    J Clin Pharm Ther; 2016 Feb; 41(1):64-9. PubMed ID: 26778812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implementation of a pharmacy benefit to a managed Medicaid population.
    Smith WW; Perry SC
    Med Interface; 1995 Dec; 8(12):84-7, 97. PubMed ID: 10153524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do open formularies increase access to clinically useful drugs?
    Walser BL; Ross-Degnan D; Soumerai SB
    Health Aff (Millwood); 1996; 15(3):95-109. PubMed ID: 8854512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do drug formulary policies reflect evidence of value?
    Neumann PJ; Lin PJ; Greenberg D; Berger M; Teutsch S; Mansley E; Weinstein MC; Rosen AB
    Am J Manag Care; 2006 Jan; 12(1):30-6. PubMed ID: 16402886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparing patient access to pharmaceuticals in the UK and US.
    Cohen J; Cairns C; Paquette C; Faden L
    Appl Health Econ Health Policy; 2006; 5(3):177-87. PubMed ID: 17132032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulary restrictions on atypical antipsychotics: impact on costs for patients with schizophrenia and bipolar disorder in Medicaid.
    Seabury SA; Goldman DP; Kalsekar I; Sheehan JJ; Laubmeier K; Lakdawalla DN
    Am J Manag Care; 2014 Feb; 20(2):e52-60. PubMed ID: 24738555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Medicaid drug program in Louisiana: critique of the Hefner-Pracon Study.
    Rucker TD; Morse ML
    Am J Hosp Pharm; 1980 Oct; 37(10):1350-3. PubMed ID: 6775531
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmaceuticals issue brief: managed care drug formularies: year end report-2003.
    MacEachern L
    Issue Brief Health Policy Track Serv; 2003 Dec; ():1-8. PubMed ID: 14969259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. US Medicaid drug formularies: do they work?
    Moore WJ; Newman RJ
    Pharmacoeconomics; 1992; 1(Suppl 1):28-31. PubMed ID: 10146928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coverage and prior authorization of psychotropic drugs under Medicare Part D.
    Huskamp HA; Stevenson DG; Donohue JM; Newhouse JP; Keating NL
    Psychiatr Serv; 2007 Mar; 58(3):308-10. PubMed ID: 17325102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coming of Medicaid.
    Navarro RP
    Med Interface; 1995 Dec; 8(12):82-3. PubMed ID: 10153523
    [No Abstract]   [Full Text] [Related]  

  • 18. And the beat goes on: formulary restriction, generic substitution, prior authorization, drug utilization, and now therapeutic interchange.
    Burkhart CG
    J Drugs Dermatol; 2004; 3(1):11. PubMed ID: 14964740
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of closing a Medicaid formulary on the prescription of analgesic drugs.
    Smith MC; Maclayton DW
    Hosp Formul; 1977 Jan; 12(1):36-8, 41. PubMed ID: 10297022
    [No Abstract]   [Full Text] [Related]  

  • 20. Employer drug benefit plans and spending on prescription drugs.
    Joyce GF; Escarce JJ; Solomon MD; Goldman DP
    JAMA; 2002 Oct; 288(14):1733-9. PubMed ID: 12365957
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.